A prodrug form of monomethyl fumarate
Related Products
Active Metabolite(s)
27813Monomethyl fumarate
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Diroximel Fumarate

Item No. 29111

Technical Information
Formal Name
(2E)-butenedioic acid, 1-[2-(2,5-dioxo-1-pyrrolidinyl)ethyl] 4-methyl ester
CAS Number
1577222-14-0
Synonyms
  • BIIB098
Molecular Formula
C11H13NO6
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 10mg/mLDMSO: 10mg/mLDMSO:PBS (pH 7.2) (1:3): 0.25mg/mL
SMILES
COC(/C=C/C(OCCN1C(CCC1=O)=O)=O)=O
InChi Code
InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+
InChi Key
YIMYDTCOUQIDMT-SNAWJCMRSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Diroximel fumarate is a prodrug form of monomethyl fumarate (Item No. 27813).1 It undergoes esterase cleavage in the gut to release monomethyl fumarate. Formulations containing diroximel fumarate have been used in the treatment of relapsing-remitting multiple sclerosis.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Naismith, R.T., Wolinsky, J.S., Wundes, A., et alDiroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Mult. Scler. (2019).